# Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

> **NCT00261807** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 25 (actual)

## Conditions studied

- Fasciitis, Necrotizing
- Severe Necrotizing Skin and Soft Tissue Infections
- Fournier's Gangrene

## Interventions

- **DRUG:** Daptomycin 6mg/kg/day

## Key facts

- **NCT ID:** NCT00261807
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261807, "Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00261807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*